On the Field with Will Levis

NFL Quarterback

Will Levis’ struggle with glasses and contacts

As a quarterback for the University of Kentucky Wildcats, Will Levis knew the importance of clear vision. Every move, every pass, and every decision depended on it. But being nearsighted and wearing contact lenses posed challenges that often impacted his game.

“I've had to deal with glasses and contact lenses for my whole adolescent and adult life. I've even had my contact lenses knocked out during a game, taking away my ability during a play or a drive.”

When he was drafted by the Tennessee Titans in 2023, the stakes became even higher. Transitioning to professional football meant he couldn't afford any distractions, especially from his vision.

“I wanted to do what was best for me and have the best edge that I could get. When looking at all the options, it became clear that EVO ICL was the best option for me.”

Will Levis testimonial page video thumbnail

Why Will Levis chose EVO ICL lenses

When doing his research on EVO ICL, a couple of benefits stood out to Will:

  • Safety: Unlike other procedures, EVO ICL doesn’t involve the permanent removal of corneal tissue.
  • Comfort: The EVO ICL procedure doesn't cause dry eye syndrome.
  • Removability: EVO ICL lenses can be safely removed by a doctor if ever needed. This added flexibility gave Will peace of mind.

On the field, EVO ICL gives me more confidence in my game and my ability. EVO ICL lets me play more freely, not having to worry about the daily hassles that come with wearing contact lenses.”

My day-to-day life has changed drastically. Being able to wake up and see clearly right away is such an underrated aspect of life. The difference in my eyesight from before and after the EVO ICL procedure is night and day. I truly know that getting EVO ICL is one of the best decisions I've made in my entire life.

Will Levis has EVO ICL lenses and is sponsored by STAAR Surgical.

References

1. Packer M. The Implantable Collamer Lens with a central port: review of the literature. Clin Ophthalmol. 2018;12:2427-2438.

2. Martínez-Plaza E, López-Miguel A, López-De La Rosa A, et al. Effect of the EVO+ Visian Phakic Implantable Collamer Lens on Visual Performance and Quality of Vision and Life, Am J Ophthalmol 2021;226: 117-125.

3. Packer M. Evaluation of the EVO/EVO+ Sphere and Toric Visian ICL: Six Month Results from the United States Food and Drug Administration Clinical Trial. Clin Ophthalmol. 2022;16:1541-53.

4. Parkhurst GD. A prospective comparison of phakic collamer lenses and wavefront-optimized laser-assisted in situ keratomileusis for correction of myopia. Clin Ophthalmol. 2016;10:1209-1215.

5. Zhang H, Deng Y, Ma K, Yin H, Tang J. Analysis on the changes of objective indicators of dry eye after implantable collamer lens (ICL) implantation surgery. Graefes Arch Clin Exp Ophthalmol. 2024 Jul;262(7):2321-2328.

6. Albo C, Nasser T, Szynkarski DT, Nguyen N, Mueller B, Libfraind L, Parkhurst G. A Comprehensive Retrospective Analysis of EVO/EVO+ Implantable Collamer Lens: Evaluating Refractive Outcomes in the Largest Single Center Study of ICL Patients in the United States. Clin Ophthalmol. 2024 Jan 9;18:69-78.